Prothena Corporation plc (PRTA) Stock price, Description, News & Info

#Thinksabio latest news

Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy